We are live on ! Find out more
VNDA icon

Vanda Pharmaceuticals
VNDA

178 hedge funds and large institutions have $723M invested in Vanda Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 59 increasing their positions, 63 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 15

38% more capital invested

Capital invested by funds: $524M → $723M (+$199M)

9% more funds holding

Funds holding: 164 → 178 (+14)

1.2% more ownership

Funds ownership: 99.51% → 100.71% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 63

71% less call options, than puts

Call options by funds: $731K | Put options by funds: $2.51M

Holders
178
Holders Change
+14
Holders Change %
+8.54%
% of All Funds
3.15%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
29
Increased
59
Reduced
63
Closed
15
Calls
$731K
Puts
$2.51M
Net Calls
-$1.78M
Net Calls Change
-$180K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$7.36M
2
BlackRock
BlackRock
New York
+$6.46M
3
Millennium Management
Millennium Management
New York
+$5.73M
4
LSV Asset Management
LSV Asset Management
Illinois
+$4.59M
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$3.65M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$8.43M
2
Renaissance Technologies
Renaissance Technologies
New York
-$4.7M
3
SG Americas Securities
SG Americas Securities
New York
-$3.54M
4
State Street
State Street
Massachusetts
-$2.18M
5
WG
Winton Group
United Kingdom
-$2.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
Group One Trading
151
Group One Trading
Illinois
$46K -$22.7K -1,882 -35%
Osaic Holdings
152
Osaic Holdings
Arizona
$44K +$7.54K +626 +23%
HIA
153
Harbor Investment Advisory
Maryland
$35K +$9.59K +797 +43%
CMBA
154
C.M. Bidwell & Associates
Hawaii
$35K +$32.3K +2,680 New
Lazard Asset Management
155
Lazard Asset Management
New York
$33K +$21.7K +1,805 +232%
PNC Financial Services Group
156
PNC Financial Services Group
Pennsylvania
$32K +$7.63K +634 +35%
VCG
157
Vantage Consulting Group
Virginia
$23K +$20.8K +1,724 New
PCM
158
Penserra Capital Management
California
$16K +$9.5K +789 +169%
SFS
159
Sowell Financial Services
Arkansas
$15K +$13.9K +1,156 New
VCM
160
Versant Capital Management
Arizona
$13K +$84 +7 +0.7%
FTDI
161
First Trust Direct Indexing
Massachusetts
$9K +$7.91K +657 New
TRCT
162
Tower Research Capital (TRC)
New York
$8K -$28.9K -2,405 -79%
LC
163
Lindbrook Capital
California
$8K – – –
US Bancorp
164
US Bancorp
Minnesota
$6K -$5.75K -478 -52%
Rockefeller Capital Management
165
Rockefeller Capital Management
New York
$6K – – –
FPS
166
Fieldpoint Private Securities
Connecticut
$5K +$4.33K +360 New
IA
167
IFP Advisors
Florida
$4K +$3.55K +295 New
GLLW
168
Graves Light Lenhart Wealth
Virginia
$3K +$2.41K +200 New
PWPS
169
Pinnacle Wealth Planning Services
Ohio
$3K +$2.72K +226 New
Daiwa Securities Group
170
Daiwa Securities Group
Japan
$2K -$2.18K -181 -60%
PFBT
171
Parkside Financial Bank & Trust
Missouri
$2K +$1.65K +137 New
MGIM
172
M&G Investment Management
United Kingdom
$1.19K +$1.1M +91,270 New
Carson Wealth (CWM LLC)
173
Carson Wealth (CWM LLC)
Nebraska
$1K – – –
First Manhattan
174
First Manhattan
New York
$1K – – –
CAPTRUST Financial Advisors
175
CAPTRUST Financial Advisors
North Carolina
$1K +$662 +55 +110%
4 5 6
7
8

VNDA Hedge Fund Activity: Q4 2020 in Review

178 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Vanda Pharmaceuticals (VNDA) for Q4 2020, worth a combined $723M — up 38% from $524M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new VNDA positions and 15 closed out — a net gain of 14 holders — while 59 added to existing stakes and 63 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $7.36M. The largest seller was Citadel Advisors, cutting an estimated $8.43M.

  • 178 institutional investors held Vanda Pharmaceuticals (VNDA) as of Q4 2020, up from 164 in Q3 2020.
  • Funds reported $723M of Vanda Pharmaceuticals stock for Q4 2020, up 38% quarter-over-quarter.
  • 29 funds opened new Vanda Pharmaceuticals positions in Q4 2020 and 15 closed out, a net change of +14 holders.
  • The largest Vanda Pharmaceuticals buyer in Q4 2020 was Morgan Stanley, an estimated $7.36M added.
  • The largest Vanda Pharmaceuticals seller in Q4 2020 was Citadel Advisors, an estimated $8.43M sold.

Based on aggregated 13F filings for Q4 2020.